DocumentsDate added
Original article:
Badyal Ashima1,*, Pandey Rajesh2, Sodhi KS2, Singh Jasbir4.
Affiliation:-
1Registrar, Department of Biochemistry, GMC, Jammu, J&K, India
2Professor,3Professor and Head, Department of Biochemistry, MMIMSR, Mullana, Ambala, Haryana, India
The name of the department(s) and institution(s) to which the work should be attributed:
1. Department of Biochemistry, GMC, Jammu, J&K, India
2. Department of Biochemistry, MMIMSR, Mullana, Ambala, Haryana, India
*To whom it corresponds:-
Dr. Ashima Badyal.
214-A Shastri Nagar, Jammu, J&K State, India- 180004
Contact no: +91-9796825414+91-9796825414 .
Abstract:
Context: Controversial reports are available regarding the status of magnesium on glycemic control in type 2 diabetes mellitus. Serum magnesium levels are not investigated in routine practice despite its significance. Aims: The present study was designed to compare the serum magnesium of type 2 diabetic patients without complications with those of non diabetic controls and to assess the relationship between these two. Setting and Design: Prospective cross sectional study in rural setting of Haryana. Materials and Methods: 50 healthy controls and 100 patients with type 2 diabetes mellitus without complications were recruited from Medicine OPD of MMIMSR, Mullana, Ambala (Haryana), and their serum glucose and serum magnesium levels were measured and compared. Statistical Analysis: By SPSS version 12 [SPSS v12 (SPSS Inc., Chicago, IL)]. Results: The serum magnesium levels were significantly lower in diabetic subjects. Conclusions: Serum magnesium status needs to be routinely checked in diabetic patients and, if reduced, need to be appropriately corrected.
Keywords: Complications; diabetes mellitus; glucose; magnesium.
REFERENCES
1.Parizadeh SM, Faal G, Valaee L. Maternal serum magnesium level and low birth Weight neonate. Int J Prev Med 2013; 4(12): 1476–79.
2.Zimet P, Albert KG, Shaw J. Global and societal implications of diabetes epidemic. Nature 2001; 414: 782-87.
3.Nair P, Christensen MS, Christensen C, Masbad S, Transbol I. Renal hypomagnesemia in human diabetes mellitus: its relation to glucose homeostasis. Eur J Clin Invest 1982; 12; 81-5.
4.Geiger H, Wanner C. Magnesium in disease. Clin Kidney J 2012; 5(1) 26-38.
5.Pham PC, Pham PM, Pham SV, Miller JM, Pham PT. Hypomagnesemia in patients with type 2 diabetes. Clin J Am Soc Nephrol 2007; 2: 366–73.
6.Dayanand CD, Krishamurthy N, Kiran S, Naveen. Evaluation of biochemical parameters evincing atherogenic potency in type 2 diabetic retinopathy. Int J Biol Med Res 2011; 2 (2):539-42.
7.Hans CP, Sialy R, Bansal DD. Magnesium deficiency and diabetes mellitus. Curr Sci 2002;83(12): 1456-63.
8.Paolisso G, Barbagallo M. Hypertension, diabetes mellitus and insulin resistance. The role of intracellular magnesium. Am J Hypertens 1997; 10 (3): 346-55.
9.Powers CA. Diabetes mellitus. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo BL,Jameson JL, editors. Harrison’s principles of internal medicine, 17th edition. United States of America (New York): Mc Graw Hill Company, Inc; 2008, p. 2275-2304.
10.Basak A. Development of a rapid and inexpensive plasma glucose estimation by two point kinetics method based on glucose–oxidase-peroxidase enzymes. Indian J Clin Biochem 2007; 22(1): 156-60.
11.Barbour HM, Davidson W. Studies on measurement of plasma magnesium: application of magnon dye method to the “monarch” centrifugal analyzer. Clin Chem 1988; 34: 2103-5.
12.Cockram C, Chan J. The epidemiology of diabetes in the Western Pacific Region (excluding Japan). In: Turle J, Kaneko T, Osato S, Eds. Diabetes in the New Millennium. Sydney, Pot Still Press, 1999, p. 11–22.
13.Wilson WF, Anderson M, Kannel B. Epidemiology of diabetes mellitus in the elderly the Framingham study. Am J Med 1986; 80(5): 3-9.
14.Nakagami T, Qiao Q, Tuomilehto J, Ballau B, Cartensen B, Tajima N, et al. The fasting plasma glucose cut-point predicting a diabetic 2hr OGTT glucose level depends on the phenotype.Diabetes Res Clin Pract 2002; 55: 35-43.
15.Mane M, Chaudhary RG, Reddy PE. Hypomagnesemia in diabetic patient and biochemical action on cardiovascular system. Int J Biol Med Res 2012; 3(1): 1273-76.
16.Earle C, Heshka S, Gallagher D, Wang J, Sunyer X, Richard N. Serum magnesium and type 2 diabetes in African Americans and Hispanics: a new cohort study. Am J Clin Nutr 2006;25(6): 509-13.
17.Mooren FC, Kruger K, Volker F, Golf SW, Wadepuhi M, Kraus A. Oral magnesium supplementation reduces insulin resistance in non diabetic subjects- a double blind, placebocontrolled, randomized trial. Diabetes Obes Metab 2011; 13(3):281-4.
Article citation:
Badyal Ashima,Pandey Rajesh,Sodhi KS,Singh Jasbir. Decreased Serum Magnesium in Patients with Uncomplicated Type 2 Diabetes Mellitus. J Pharm Biomed Sci. 2014;04(04):361-364.Available at www.jpbms.info.
Source of support: None
Competing interest / Conflict of interest
The author(s) have no competing interests for financial support, publication of this research, patents and royalties through this collaborative research. All authors were equally involved in discussed research work. There is no financial conflict with the subject matter discussed in the manuscript.
Case report:
Banushree C Srinivasamurthy MD DNB, Ambedkar Raj Kulandaivelu MD
Affiliation:-
1Assistant Professor, Department of Pathology & Lab Medicine, AIIMS, Bhubaneswar, India
2Associate Professor, Department of Pathology, Sri Manakula Vinayagar Medical College, Puducherry, India
The name of the department(s) and institution(s) to which the work should be attributed:
1. Department of Pathology & Lab Medicine, AIIMS, Bhubaneswar, India
2. Department of Pathology, Sri Manakula Vinayagar Medical College, Puducherry, India
*To whom it corresponds:-
Dr Banushree CS.
Assistant Professor, Department of Pathology & Lab Medicine, AIIMS, Bhubaneswar, India
Contact no:-+91- 9438884174+91- 9438884174
Abstract
The most common cause of malignant ascites in women is intraperitoneal spread from an ovarian primary carcinoma, usually of the papillary serous type. Occasionally, women with serous borderline tumors present with ascites. Papillary serous neoplasms of the ovary and peritoneum need to be recognized in cytology specimens for appropriate diagnosis and/or staging purposes. Borderline serous carcinoma can go undetectable in intra-operative exploration alone, so cytological examination of peritoneal washings should be done. The distinction of reactive mesothelial cells from serous neoplasms in peritoneal fluids is possible in most patients by cell group architecture and cytological features. We encountered a rare case of borderline papillary serous carcinoma of ovary with presence of malignant cells in peritoneal washing in a forty-three year old female which helped in predicting the behavior and staging of the tumour and establishing proper line of management.
Keywords: Peritoneal washing; reactive mesothelial cells; papillary serous neoplasms; ovary.
REFERENCES
1.P. Tauchi S, N. Caraway, L. D. Truong, A. L. Kaplan, and I. Ramzy. Serous surface carcinoma of the peritoneum: useful role of cytology in differential diagnosis and follow-up. Acta Cytol. 1996. 40:429–436.
2.Lee, A, Z. W. Baloch, G. Yu, and P. K. Gupta. Mesothelial hyperplasia with reactive atypia: diagnostic pitfalls and role of immunohistochemical studies—a case report. Diagn Cytopathol. 2000. 22:113–116.
3.Zuna, R. E, M. L. Mitchell , K. A. Mulick , and W. M. Weijchert . Cytohistologic correlation of peritoneal washing cytology in gynecologic disease. Acta Cytol. 1989. 33:327–336.
4.Ziselman, E. M. , S. E. Harkavy , M. Hogan , W. West , and B. Atkinson . Peritoneal washing cytology: uses and diagnostic criteria in gynecologic neoplasms. Acta Cytol 1984;28:105–110.
5.Covell JL, Carry JB, Feldman PS. Peritoneal washings in ovarian tumors. Potential sources of error in cytologic diagnosis. Acta Cytol. 1985;29:310–6.
6.Ravinsky E. Cytology of peritoneal washings in gynecologic patients. Diagnostic criteria and pitfalls. Acta Cytol.1986;30:8–16.
7.Gurley AM, Hidvegi DF, Cajulis RS, Bacus S. Morphologic and morphometric features of low grade serous tumours of the ovary. Diagn Cytopathol.1994; 11:220–5.
8.Mulvany N. Cytohistologic correlation in malignant peritoneal washings. Analysis of 75 malignant fluids. Acta Cytol 1996;40:1231–9.
9.Johnson TL, Kumar NB, Hopkins M, Hughes JD. Cytologic features of ovarian tumors of low malignant potential in peritoneal fluids. Acta Cytol1988; 32:513–8.
10.Oscar Lin. Challenges in the Interpretation of Peritoneal Cytologic Specimens. Arch Pathol Lab Med. 2009; 133:739-742.
Article citation:
Banushree C Srinivasamurthy, Ambedkar Raj Kulandaivelu. Cytologic identification of borderline papillary serous carcinoma of ovary in peritoneal washing cytology:a case report and review of literature. J Pharm Biomed Sci. 2014; 04(04):279-283. Available at www.jpbms.info.
Source of support: None
Competing interest / Conflict of interest
The author(s) have no competing interests for financial support, publication of this research, patents and royalties through this collaborative research. All authors were equally involved in discussed research work. There is no financial conflict with the subject matter discussed in the manuscript.
Copyright © 2014 Banushree C Srinivasamurthy, Ambedkar Raj Kulandaivelu.This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Original Article
Bagbi Baribefe M1,* , Omotoso Abayomi E2, Chiagozie Ochuba3
Affiliation:-
1,3Department of Clinical Pharmacy and Experimental Pharmacology, Faculty of Pharmaceutical Sciences, University of Port-Harcourt, Nigeria
2Department of Medicinal and Pharmaceutical Chemistry, University of Port-Harcourt, Nigeria
The name of the department(s) and institution(s) to which the work should be attributed:
Department of Clinical Pharmacy and Experimental Pharmacology, Faculty of Pharmaceutical Sciences, University of Port-Harcourt, Nigeria
Department of Medicinal and Pharmaceutical Chemistry, University of Port-Harcourt, Nigeria
*To whom it corresponds:-
Dr. Bagbi Baribefe M.
Department of Clinical Pharmacy and Experimental Pharmacology, Faculty of Pharmaceutical Sciences, University of Port-Harcourt, Nigeria
Abstract
This study evaluated the quality of seven commercially available (European or Asian sourced) Atorvastatin Calcium(ATV-Ca) tablets products marketed in Southern-Nigeria, with a view to determine their interchangeability in clinical practice. Survey of the assessed Atorvastatin brands was carried out in some southern-Nigeria cities based on their prices. Drug products’ quality assessment included visual examination for their organoleptic properties; tests for weight variation, friability, hardness, disintegration time, dissolution profile and assay for Atorvastatin content. A validated UV-Vis Spectro-photometric method was employed in the assay. Findings indicated that the European sourced samples were 2 to 3 times more expensive than the Asian sourced samples. All brands complied with the official specifications for friability and disintegration time, but sample F failed the test for weight variation (%). Sample C and F also failed the test for tablet hardness. Assay results revealed that with the exception of samples D, F and G, other samples contained >90% (w/w) of labeled potency. Four out of the seven samples attained 70% dissolution within 40min. Comparison of the dissolution profile of the different samples were carried out by model-independent approaches of difference factor(f1), similarity factor(f2) and dissolution efficiency (% DE). These results demonstrated that the European sourced Atorvastatin calcium tablets may after all not be interchangeable with those sourced from Asia.
Keywords: Atorvastatin calcium; Interchangeability; Similarity factor and European.
Article citation:
Bagbi Baribefe M, Omotoso Abayomi E, Chiagozie Ochuba. Comparative Assessment of Quality Brands of Atorvastatin Tablets Marketed in Southern Nigeria. J Pharm Biomed Sci. 2014;04(03):318-326. Available at www.jpbms.info.
REFERENCES
1.Nagaraju P, Pasumarthy, Gopal NV, Srinivas VDN and Padma SVN. Spectrophotometric methods for the determination of Atorvastatin calcium in pure and its Pharmaceutical Dosage forms. Asian J Research Chem. 1 (2):2008; 64-66.
2.The British Pharmacopoeia; The Stationary office London 2011
3.Salam WA, Dumitru. Enhancement of solubility and dissolution rate of different forms of Atorvastatin calcium in direct compression tablet formulas. Farmacia 2009;57(3):290-300.
4.United State Pharmacopoeia and National Formulary USP 34 NF 29. Convention, Mack, Easton, PA; 2011, 1949.
5.British Pharmacopoeia (2005) Volume 4, Appendix XII H A 273, Table 2.9. 5-1
6.Moshood OA, Oladapo I, Patricia NN, Olubukola OO. Quality of Brands of Atorvastatin calcium tablets marketed in Lagos, Nigeria. Int. J Pharmacy & Pharmacol. 2012;1 (1):001-007.
7.Tanjinatus OO, Ishra N, Ashraful Islam SM. Comparative in vitro Bioequivalence Analysis of some Generic tablets of Atorvastatin, a BCS class II compound. Bangladesh Pharmaceutical Journal 2011;14(1):61-66.
8.Fawzia K, Mingzhong L, Walkeria S(2013). Comparison of in vitro Dissolution Tests for commercially Available Aspirin Tablets. Dissolution technologies pp 48-58.
9.Moore JW, Hanner HH. Mathematical comparison of Dissolution profile. Pharm Tech. 1996; 20(6):64-74.
10.Costa FO, Sousa jj, Pais AACC, Formosinho SJ. Comparison of dissolution profile of Ibuprofen pellets. J Control Release 2003; 89 (2):199-212.
11.Costa P, Sousa Lobo. Modeling and comparison of dissolution profiles. J. Pharm. Sci. 2001; 13 (2):123-133.
12.Babalola CP (2004). Bioavailability and Bioequivalence (BA/BE) assessment. In Olaniyi AA et al., eds. Towards better quality assurance, 1st ed. Ibadan Nigeria, Omoadade Printing Press, 2004.
13.Adegbolagun OA, Ololade OA, Osumah SE. Comparative evaluation of the biopharmaceutical and chemical equivalence of some commercially available brands of ciprofloxacin hydrochloride tablets. Trop. J Pharm. Res. 2007; 6: 737-745.
14.Tousey MD. Tablet pro: A tablet making training resource for tablet making professional. Techceuticals.2001;4(1);1-15. www dipharma.com/TP_V4 pdf [Assessed on 09-03-2012]
15.Kalakuntla R, Veerlapati U, Chepuri M, Rapavla R. Effect of various super disintegrant on hardness, disintegration and dissolution of drug from dosage form. J Adv. Sci. Res. 2010; 1(1): 15-19.
16.Salam WA, Dumitru L. (2009) Enhancement of solubility and dissolution rate of different forms of Atorvastatin calcium in direct compression tablet formulas.Farmacia. 2009;57(3):290-300.
17.Guidance for industry. Waiver of in vivo bioavailability and bioequivalence studies for immediate release solid oral dosage forms based on biopharmaceutics classification system. Silver Spring, Maryland, Department of Health and Human Services. Food and Administration Centre for Drug Evaluation and Research 2000.
18.Notes for guidance on the investigation of bioavailability and bioequivalence. London, European Agency for the evaluation of medical products, 2000 (CPMP/EWP/QWP/1401/98).
19.Zaid A, Rinno T, Jaradat N, Jodeh S, Khammash S (2013). Interchangeability between Paracetamol tablet marketed in Palestine: Is there a quality reason for a higher price? EMHJ.2013; 19(6); 542-546.
20.Dressman J, Butler J, Hempenstall J Reppas C. The BCS: Where do we go from here? Pharmaceutical Technology.2001; 25: 68-76.
21.Voegele D. Drug release in vitro- an aid in clinical trials? Methods and findings in Experimental and clinical Pharmacology.1999; 21 (1): 55-62.
22.Adegbite AI, Adegbolagun OM. Evaluation of physicochemical equivalence of three brands of commercially available Quinine sulphate tablets from South Western part of Nigeria. Afr. Health Sci. 2011; 11(2) 197-203.
23.Dissolution Testing of immediate release solid oral dosage forms; Guidance for industry, US Department of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER), US Government Printing Office: Washington, DC, 1997.
24.Anderson NH, Bauer M, Boussac N et al.,. An Evaluation of fit factor and dissolution efficiency for the comparison of in vitro dissolution profiles. J Pharm. Biomed. Anal. 1998; 17, 811-822.
25.Chiba, Y., Kohri, N., Iseki, K. and Miyazaki, K. Improvement of dissolution and bioavailability for mebendazole, an agent for human echinococcosis, by preparing solid dispersion with polyethylene glycol. Chem. Pharm. Bull. 1991; 39, 2158-2160.
26.Colhoun HM., Betteridge DJ., Durrington PN., et al - Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial; Lancet. 2004; 364:685.
27.Lea AP, McTavish D: Atorvastatin: A review of its pharmacology and therapeutic potential in the management of hyperlipidaemias. Drugs 1997; 53:828-847.
28.Ahmed S, Rasul A, Masood Z (2011). Spectrophotometry in Pharmaceutical Analysis. Germany, LAP Lambert Academic Publishing.
29.Dhabale PN, Gharge DS.Simultaneous spectrophotometric estimation of Atorvastatin and Fenofibrate in bulk drug and Dosage form by using simultaneous equation method. Int. J. of ChemTech Research. 2010; 2(1);325-328.
30.Vijya GM, Arabinda P, Shubhrajit M, Sathees SM (2013). A new method for estimating Atorvastatin in tablet with its stability studies by using RP-HPLC. Int. J. Pharm. & Ind. Res. 2013;03 (01): 27-33.
31.Wani TA, Khalil NY, Abdel-Rahman HM, Darwish IA. Novel microwell-based Spectrophotometric assay for Determination of Atorvastatin Calcium in Pharmaceutical Formulations. Chemistry Central Journal.2011; 5:57.
Source of support: None
Competing interest / Conflict of interest
The author(s) have no competing interests for financial support, publication of this research, patents and royalties through this collaborative research. All authors were equally involved in discussed research work. There is no financial conflict with the subject matter discussed in the manuscript.
Copyright © 2014 Bagbi Baribefe M, Omotoso Abayomi E, Chiagozie Ochuba. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Original article
Sushma Katkuri1,*,Pravinpisudde1,Nithesh Kumar1,Syeda Farha Hasan2
Affiliation:-
1Assistant Professor, Department of Community Medicine, Deccan College of Medical Sciences, Hyderabad,A.P, India
2Final Year MBBS student, Deccan College of Medical Sciences, Hyderabad, A.P, India
The name of the department(s) and institution(s) to which the work should be attributed:
Department of Community Medicine, Deccan College of Medical Sciences, Hyderabad, A.P, India
*To whom it corresponds:-
Dr Sushma Katkuri*
House No-9 Bhavya Shri Krishna Avenue
Pragati Nagar, Quthbulapur Mandal, Hyderabad-500009, A.P, India
Contact no:-+91- 9160144007
Abstract
A Study to Assess Knowledge, Attitude and Practices of Menstrual Hygiene among School Going Adolescent Girl’s in Hyderabad, India
Background: Adolescent girls constitute a vulnerable group not only with respect to their social status but also in relation to health. Menstruation is regarded as unclean or dirty in Indian society. Although it is a natural process, is linked with several misconceptions and practices which sometimes results into adverse health outcomes. Poor personal hygiene and unsafe sanitary conditions result in the girls facing many gynaecological problems Aims & Objectives: To study knowledge, attitude and practices about menstrual hygiene among adolescent girls. Materials & Methods: A community based cross sectional study was done in school going adolescent girls from a Secondary school near Deccan College of Medical Sciences, Hyderabad. A randomly selected group of 250 adolescents girl’s in the age group of 12 -15 years from class 7th -10th were included in the study. Results: The subjects were maximum in the age group of 13 years (38%) and 14years (37.2%). Almost 54% of the girl’s were aware about the menstrual cycles. 60% reported that mothers were the main source of information about menstrual cycles. Certain faulty practices were followed during menstruation like 54.4 % were not allowed to visit holy places and 45 % said that they are restricted to perform any household activities. Conclusion: The study reflects that the awareness about menstruation was good but still knowledge about certain details regarding menstruation was not known. Therefore the deficiencies can be fulfilled by providing proper information to them by school teachers, health educators and mothers.
Keywords: Adolescents; menstruation; practices; attitudes.
REFERENCES
1.WHO/UNFPA/UNICEF. Programming for Adolescent Health and Department. Report of WHO/UNFPA/UNICEF Study Group on Programming for Adolescent Health. Technical Report Series. Geneva. 1996 No. 886
2.Abera Y. Menarche, Menstruation Related Problems and Practices Among Adolescent High School Girls in Addis Ababa. Thesis of Master degree Addis Ababa University 2003/04: P.9.
3.Drakshayani D K, Venkata RP. A study on menstrual hygiene among rural adolescent girls. Indian Journal Of Medical Sciences.1994 Jun;48 (6):139-143.
4.Dasgupta A and Sarkar M. Menstrual Hygiene: How hygienic is the adolescent girl? Indian Journal of Community Medicine. 2008;33( 2):77-80.
5.Bhatia JC, Cleland J. Self Reported Symptoms of Gynaecological Morbidity and their Treatment in South India. Studies in Family planning.1995 Jul-Aug; 26(4):203-16.
6.Mehta S.(Ed.) 1995. Adolescent Girl: An Indian Perspective. New Delhi: Mamta Health Institute for Mother and Child.
7.Greene E Margaret 1997. Watering the Neighbours Garden. New Delhi: Population Council (Working Paper. No. 7).
8.Paul D 2007.A Report of an ICMR Funded Research Project: Knowledge and Practices of Adolescent Girls Regarding Reproductive Health with Special Emphasis on Hygeine during Menstruation. New Delhi: National Institute of Public Cooperation and Child Development(NIPCCD).
9.Dipali Nemade, Seema Anjenaya, and Ruplai Gujar. Impact of health education on knowledge and practices about menstruation among adolescent girls of Kalamboli Navi-Mumbai. Health and Population and Issues. 2009;32 (4):167-175.
10.Abhay Bhausaheb Mudey, Naveeta Kesharwani, Gargi Abhay Mudey, Ramchandra C Goyal A Cross-sectional Study on Awareness Regarding Safe and Hygienic Practices amongst School Going Adolescent Girls in Rural Area of Wardha District, India. Global Journal of Health Science. 2010 Oct; 2(2): 225-231.
11.Echendu Dolly Adinma, J.I.B. Adinma. Perceptions and Practices on Menstruation Amongst Nigerian Secondary School Girls. African Journal of Reproductive Health. 2008 April;12(1):74-83.
12.Rajni Dhingra, Anil Kumar and Manpreet Kour. Knowledge and Practices Related to Menstruation among Tribal (Gujjar) Adolescent Girls. Ethno-Med.2009;3(1):43-48.
13.Lakshmi G, Sambasiva Rao R, Giridhar L. Perceptions and practices regarding menstruation: A comparative study in Savara and Jatapu tribal adolescent girls in Srikakulam district. Asian Journal of Pharmaceuticals and Health sciences. 2013: July-Sept;3(3): p748-752.
14.Shabnam Omidyar, Khyrunnisa Beguam. Factors influencing hygienic practices during menses among girls from south India-A cross-sectional study. International journal of Collaborative Research on Internal Medicine & Public Health. 2010: Dec;2(12):411-423.
15.Lawan UM, Nafisa Wali Yusuf, Aisha Bala Musa. Menstruation and Menstrual hygeine amongst Adolescent School Girls in Kano, Northwestern Nigeria. African Journal of Reproductive Health.2010:Sept;14(3):201-208.
Article citation:
Sushma Katkuri, Pravin pissude, Nithesh Kumar, Syeda Farha Hasan Abedi. A Study to Assess Knowledge, Attitude and Practices about Menstrual Hygiene Among School Going Adolescent Girl’s in Hyderabad, India. J Pharm Biomed Sci 2014; 04(04):298-302. Available at www.jpbms.info.
Source of support: None
Competing interest / Conflict of interest
The author(s) have no competing interests for financial support, publication of this research, patents and royalties through this collaborative research. All authors were equally involved in discussed research work. There is no financial conflict with the subject matter discussed in the manuscript.
Copyright © 2014 Sushma Katkuri, Pravin pissude ,Nithesh Kumar, Syeda Farha Hasan Abedi. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Original article
Panigrahi R1,* Maheshwari A2
Affiliation:-
1Associate professor, 2P.G Student,Department of Otorhinolaryngology, Hi-Tech Medical college and Hospital, Bhubaneswar, Odisha, India
The name of the department(s) and institution(s) to which the work should be attributed:
Department of Otorhinolaryngology, Hi-Tech Medical College and Hospital, Bhubaneswar, Odisha, India
*To whom it corresponds:-
Dr. Rajlaxmi Panigrahi, M.S.
Associate professor,
Department of Otorhinolaryngology, Hi-Tech Medical College and Hospital, Bhubaneswar, Odisha, India
Contact no:- +91- 09437113636+91- 09437113636
Abstract
Background: Oral submucosal fibrosis (OSMF) is a chronic, crippling condition of oral cavity with a well recognized malignant potential. Its multifactorial etiology and treatment regimes are yet to be standardized. In the present study, the efficacy of combination of triamcinolone acetonide and hyaluronidase has been compared with triamcinolone acetonide alone, given intralesionally at 14 days interval.
Material and method: In a prospective study, patients of OSMF were randomly divided into 2 groups (A and B). Patients in group A received a combination of triamcinolone acetonide and hyaluronidase. Patients in group B received triamcinolone acetonide (1500 IU) alone. In both groups, medication was injected submucosally at 14 days interval, for a total of 8 doses. Treatment outcome was evaluated in terms of improvement in mouth opening and symptom score. Students paired ‘t’ test was used for result comparison.
Result: Patients in group A showed a statistically significant improvement than those in group B. with no complications in either group.
Conclusion: Intralesional injection of combination of triamcinolone acetonide and hyaluronidase is superior to triamcinolone alone, in respect to improvement in symptoms and patient convenience. A follow up study is needed to assess the long term effects.
Keywords: Oral Submucosal Fibrosis [OSMF]; Triamcinolone Acetonide [TA]; Hyaluronidase [HY].
REFERENCES
1.Pindborg JJ, Barmes D, Roed-Peterson B. Epidemiology and histology of oral leukoplakia and leukoedema among Papuans and New Guineans. Cancer 1968;22:379-84.
2.Mukherji AL, Biswas SK. Oral submucous fibrosis – A search for etiology. Indian J Otolaryngol. 1972;24:11-5.
3.Desa JV. Submucous fibrosis of the palate and cheek. Ann OtolRhin and Laryng 1957;66:1043-59.
4.Pindborg JJ. Oral submucousfibrosis : A review. Ann Acad Med Surg1989;18:603-7.
5.Anuradha CD, Devi CS. Serum protein, ascorbic acid and iron and tissue collagen in oral submucous fibrosis– a preliminary study. Indian J Med Res 1993;98:147-51.
6.Ariyawardhana A, Athukorala AD, Arulanandam A. Effect of betel chewing, tobacco smoking and alcohol consumption on oral submucous fibrosis: A case-control study in Sri Lanka. J Oral Pathol Med 2006;35(4):197-201.
7.Ahmed MS, Ali AS, Ali SA, et al. Epidemiological and etiological study of oral submucous fibrosis among gutkha chewers of Patna, Bihar, India. J Indian SocPedodprev Dent 2006:24(2):84.
8.ElluruVenkatesh et al: Role of Corticosteroids in Dentistry. Archives of dental sciences review article. 2010;1(1):3-11.
9.Anil GG. Text book of oral medicine.Jaypeebrothers medical publishers (P) ltd 2010.
10.Kakar PK, Puri RK, Venkatachalam VP.Oral suubmucous fibrosis–Treatment with hyalase. J LaryngolOtol 1985;99:57-59.
Source of support: None
Competing interest / Conflict of interest
The author(s) have no competing interests for financial support, publication of this research, patents and royalties through this collaborative research. All authors were equally involved in discussed research work. There is no financial conflict with the subject matter discussed in the manuscript.
Article citation:
Panigrahi R, Maheshwari A. A prospective, randomized double blind study comparing intralesional triamcinolone acetonide and hyaluronidase combination versus triamcinolone acetonide alone in the treatment of oral submucosal fibrosis. J Pharm Biomed Sci 2014;04(04):365-370. Available at www.jpbms.info.
Copyright © 2014 Panigrahi R, Maheshwari A. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.